Antiaggregative Aspirin Dosage at the Affected Vessel Wall
- ASPIRIN HAS BENEFIT IN PERIPHERAL ARTERIAL DISEASE. // Pulse;5/31/2007, Vol. 67 Issue 21, p32
The article cites a study that examines the effectiveness of low-dose aspirin in preventing vascular events in peripheral arterial disease patients. Random distribution of patients into four groups is conducted. Groups include patients administered with aspirin 100mg daily, antioxidant vitamins,...
- T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women. Kaplan, Robert C.; Sinclair, Elizabeth; Landay, Alan L.; Lurain, Nell; Sharrett, A. Richey; Gange, Stephen J.; Xiaonan Xue; Hunt, Peter; Karim, Roksana; Kern, David M.; Hodis, Howard N.; Deeks, Steven G. // Journal of Infectious Diseases;2/1/2011, Vol. 203 Issue 3, p452
Background. Individuals infected with human immunodeficiency virus (HIV) have increased risk of cardiovascular events. It is unknown whether T cell activation and senescence, 2 immunologic sequelae of HIV infection, are associated with vascular disease among HIV-infected adults. Methods. T cell...
- Low-Dose Aspirin May Prevent Growth and Later Surgical Repair of Medium-Sized Abdominal Aortic Aneurysms. Lindholt, Jes S.; Sorensen, Henrik T.; Michel, Jean B.; Thomsen, Henrik F.; Henneberg, Eskild W. // Vascular & Endovascular Surgery;Aug/Sep2008, Vol. 42 Issue 4, p329
Experimental data suggest that aspirin-induced platelet inhibition may retard growth of abdominal aortic aneurysms. In this article, whether low-dose aspirin use is associated with reduced aneurysm progression and subsequent need for surgery is examined. In this observational cohort study within...
- Prophylactic aspirin use in the adult general population. Trinder, P.; Rajaratnam, G.; Lewis, M.; Croft, P. // Journal of Public Health Medicine;Dec2003, Vol. 25 Issue 4, p377
Background The aim of the study was to establish the prevalence and patterns of aspirin use in people with vascular problems. Methods A cross-sectional population survey was carried out on a stratified random sample of 10 000 adults aged 35 and over in North Staffordshire. Results A total of...
- Long-term prescription of aspirin for CHD. Clark, Andrew // GP: General Practitioner;12/8/2006, p35
The article presents a question and its answer related to the risks associated with hypertensive persons receiving aspirin. The expert says that aspirin is prescribed long-term in patients with established vascular disease. Patients with hypertension who receive aspirin can suffer from...
- Mï¿½nckeberg's Sclerosis: An Unusual Presentation A Case Report. Top, Cihan; Cankir, Zeki; Silit, Emir; Yildirim, Sukru; Danaci, Mehmet // Angiology;Jul/Aug2002, Vol. 53 Issue 4, p483
Discusses the case of a 20-year old male patient presenting with Monckeberg's sclerosis, which is the calcification of the media of peripheral arteries. Disease background; Laboratory findings.
- Peripheral arterial disease. Weiner, Shepard D.; Reis, Ernane D.; Kerstein, Morris D. // Geriatrics;Apr2001, Vol. 56 Issue 4, p20
Provides information about peripheral arterial disease (PAD). Pathophysiology; Clinical features of a patient with PAD; Risk factors for PAD: Diagnosis; Disease management techniques.
- The aspirin papers. Underwood, M.J.; More, R.S. // BMJ: British Medical Journal (International Edition);1/8/94, Vol. 308 Issue 6921, p71
Features the benefits of aspirin to patients with vascular disease and those undergoing revascularization. Side effects of aspirin use; Enhancement of patency of coronary vein grafts; Reduction of incidence of pulmonary embolism in patients with deep vein thrombosis.
- Vascular viewpoint. Anand, Sonia S // Vascular Medicine;2002, Vol. 7 Issue 2, p157
Question: Among high-risk patients with vascular disease treated with aspirin, is incomplete suppression of thromboxane generation associated with an increased risk of recurrent cardiovascular events? Population: Men and women = 55 years of age who had a history of coronary artery disease,...